Barclays Maintains Underweight on Clarivate, Lowers Price Target to $2

Benzinga · 1d ago
Barclays analyst Manav Patnaik maintains Clarivate (NYSE:CLVT) with a Underweight and lowers the price target from $2.5 to $2.